In this week’s issue:
Please note these important changes to the NSERC Discovery Grant Program – due November 1, 2011
Revision: August 4, 2011
Applicants to the Discovery Grants program will see the following modifications to the on-line application:
- Proposal page: Applicants are asked to use headings (recent progress, objectives, literature review, methodology, impact) when writing their proposal;
- Contribution to Highly Qualified Personnel: Applicants are now required to provide, in a maximum of one page, detailed information about their contribution to the training of highly qualified personnel;
- Budget Justification: The maximum number of pages is now limited to two pages;
- References: The maximum number of pages has increased from one to two pages; and
- Other Research Support page: It is now mandatory for applicants who currently hold, or have applied for, research support from the Canadian Institutes of Health Research (CIHR) or the Social Sciences and Humanities Research Council of Canada (SSHRC) to provide the summary and budget page of these proposals. Failure to do so will result in an incomplete application.
The Office of the Vice-President Research & International – Faculty Research Awards – Deadline Extension & Other Opportunities – Please see attached email.
· McLaughlin-Rotman Centre for Global Health – Southern Vaccine Advocacy Challenge
· CIHR – Evidence On Tap – Expedited Knowledge Synthesis Grant
· The Lymphatic Research Foundation – Postdoctoral Fellowship Awards Program
Awards and Honours:
· Bill & Melinda Gates Foundation – Gates Vaccine Innovation Award
· Canadian Cancer Society – 2011 Awards for Excellence
· Gairdner Symposium
· Abdallah Daar & Peter Singer discuss “The Grandest Challenge: Taking Life-saving Science From Lab to Village”
Deadline: October 24, 2011, 11:59pm ET
On September 7th, 2011 the McLaughlin-Rotman Centre for Global Health, in partnership with the Decade of Vaccines Collaboration Public and Political Support Working Group, launched the Southern Vaccine Advocacy Challenge (SVAC). This program aims to fund innovative ideas to strengthen public and political support for vaccines in low- and middle-income countries.
The SVAC will award five grants of up to $10,000 USD each to support innovative advocacy initiatives around a specific vaccine-related event, issue or policy. Proposals should specifically address one or more of the following challenges:
- Secure in-country and donor support for new and existing vaccines; and,
- Build broad public demand in-country for, and uptake of, vaccines.
Organizations based in low- and middle-income countries are eligible to apply for funding. Each grant will be selected based on the project’s likelihood for impact, innovation and creativity, scalability, and technical merit and execution plans. Winners will be informed of their award in December. The work is expected to commence in January 2012 and conclude in June 2012.
Please click the title link for the RFP and Application form.
Registration Deadline: November 8, 2011
Application Deadline: January 10, 2012
Focused on: Evidence-Informed Healthcare Renewal
Healthcare System Financing, Sustainability and Governance
Competition Results Announced: March 2012
Funds Available: $100,000 for 6 months
Policy decisions must be made quickly — so quickly that research can often be left behind. Expedited Knowledge Synthesis speeds up the research process so that the best evidence arrives just in time for policy.
A series of priority synthesis questions related to health care financing and funding, sustainability of the health care system, as well as governance and accountability have been identified by collaborating Ministries of Health across Canada and are detailed within this Funding Opportunity. Research teams interested in answering one or more of these questions are invited to register with CIHR by November 8, 2011. For each synthesis question, a teleconference will be held with registered teams and the relevant ministry partner to discuss and refine the synthesis question. Teleconference dates/times (end of November) will be provided to registered teams.
For researchers this is a rare opportunity to work directly with senior-level policy-makers. For policy-makers, this is an opportunity to have access to high-quality research syntheses, tailored to their needs, and in their hands quickly.
How to apply: see website above
For more information:
Contact Jennifer Campbell at (613) 941-0805 or Jennifer.email@example.com
Deadline: January 10, 2012 1:00pm Eastern Time
The Lymphatic Research Foundation (LRF) is pleased to announce the 2012 Grant Cycle of the LRF Postdoctoral Fellowship Awards Program. The goal of the Program is to expand and strengthen the pool of outstanding junior investigators in the field of lymphatic research. The awards will support investigators who have recently received their doctorates, a critical point in career development when young scientists choose their lifelong research focus.
Examples of funding areas include but are not limited to basic, translational or clinical investigations into normal and aberrant lymphatic endothelial biology; mechanisms of normal and pathological lymphangiogenesis; imaging lymphatic function and structure; animal models of lymphatic system disorders; and the cross-talk between the lymphatic and the immune systems.
Projects in lymphocyte biology, leukemia, lymphoma and conditions secondary to lymphedema such as cutaneous infections are outside the scope of this program.
Funding Period and Amount of Award
July 1, 2012 – June 30, 2014
Two-year fellowships from
$82,000 – $95,000 (U.S. currency)
For further details including eligibility, please see the website above.
AWARDS AND HONOURS:
Deadline: November 17, 2011
The Bill & Melinda Gates Foundation is now accepting nominations for the Gates Vaccine Innovation Award to recognize, celebrate, and spur transformative ideas for achieving impact through the delivery of vaccines.
The award winner will be recognized with $250,000 (U.S.), featured on our website, and personally acknowledged by Gates Foundation leadership.
It is open to individuals from any discipline who work on delivery of vaccines. Candidates from academic institutions, governments, health care facilities, research institutions, non-profit organizations and for-profit companies may be nominated.
For more information including eligibility and criteria, please visit the website above.
Deadline: November 30, 2011
The Canadian Cancer Society is currently accepting nominations for four excellence awards:
· The Canadian Cancer Society Robert L. Noble Award
· The Canadian Cancer Society O. Harold Warwick Award
· The Canadian Cancer Society William E. Rawls Award
· The Canadian Cancer Society Young Investigator Award
For more information please see the attachment.
Date: October 24, 2011 4 – 6pm
Location: Life Sciences Centre, Lecture Theatre 1 (LSC 1), UBC, 2350 Health Sciences Mall
Don’t miss this opportunity to listen to two dynamic and high profile researchers at the 2011 Gairdner Vancouver Symposium!
This free public lecture will feature:
Dr. Howard Cedar [2011 Canada Gairdner International Award Recipient],
Dr. Michael Hayden [2011 Canada Gairdner Wightman Award Recipient]
More information about the symposium and poster can be found at the link above.
More information about the Gairdner Foundation can be found at http://www.gairdner.org/
For questions or more information please contact Seetha at firstname.lastname@example.org
Abdallah Daar & Peter Singer discuss “The Grandest Challenge: Taking Life-saving Science From Lab to Village”
Date: October 26, 2011 5:30pm
Location: Michael Smith Laboratories Auditorium, University of British Columbia, 2185 East Mall
Department of Family Practice, Faculty of Medicine, University of British Columbia & Random House Canada invites you to attend a discussion with Abdallah Daar and Peter Singer on their book:
THE GRANDEST CHALLENGE
Taking Life-saving Science From Lab To Village
“Our inspiration comes from one simple fact: If your home is in Canada, the United States or Germany you can expect to live into your eighties. If your home is in Swaziland, Mozambique, or Zambia, your life expectancy is half that long. We are poised to experience a revolution in science, one with extraordinary potential to improve human health and welfare. Will we use our power to benefit the few or for the good of all? That is the quest we explore in this book.”
RSVP to email@example.com
Books will be available at the event. ($32.95 via cash/credit card)
ABDALLAH DAAR was born in Tanzania. He is a Professor at Dalla Lana School of Public Health and of Surgery at the University of Toronto, and Director of Ethics and Commercialization at the McLaughlin-Rotman Centre for Global Health. He is the recipient of the UNESCO Avicenna Prize for Ethics of Science, and often advises governments and the UN, UNESCO, WHO and OECD on global health.
PETER SINGER is Director of the McLaughlin-Rotman Centre for Global Health, Professor of Medicine at the University of Toronto and CEO of Grand Challenges Canada. He has advised the Bill & Melinda Gates Foundation, the UN Secretary-General’s Office, the Government of Canada, and Pepsico Inc. He is also a sought-after commentator and public speaker. Singer was appointed an Officer of the Order of Canada in 2011 for his contributions to health research and bioethics, and for his dedication to improving the health of people in developing countries.
Please see the attached poster for more information.